# KVH Industries Inc \\de\\: financial statements, quarterly

KVHI · Nasdaq · CIK 1007587 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kvhi.md) · [Financials](/companies/kvhi/financials.md) · [Filings](/companies/kvhi/filings.md) · [Insiders](/companies/kvhi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kvhi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [33.2](/filings/0001007587-24-000013.md) | [31.5 d](/filings/0001007587-25-000003.md) | [29.3](/filings/0001007587-25-000008.md) | [28.7](/filings/0001007587-25-000012.md) | [29.0](/filings/0001007587-25-000022.md) | [26.9 d](/filings/0001007587-26-000004.md) | [25.4](/filings/0001007587-26-000016.md) | [26.6](/filings/0001007587-26-000026.md) | [28.5](/filings/0001007587-25-000022.md) | [30.5 d](/filings/0001007587-26-000004.md) | [32.3](/filings/0001007587-26-000016.md) | [33.7](/filings/0001007587-26-000026.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [2.4](/filings/0001007587-24-000013.md) | [2.0 d](/filings/0001007587-25-000003.md) | [3.0](/filings/0001007587-25-000008.md) | [2.3](/filings/0001007587-25-000012.md) | [1.4](/filings/0001007587-25-000022.md) | [1.7 d](/filings/0001007587-26-000004.md) | [1.2](/filings/0001007587-26-000016.md) | [0.9](/filings/0001007587-26-000026.md) | [1.0](/filings/0001007587-25-000022.md) | [0.4 d](/filings/0001007587-26-000004.md) | [0.7](/filings/0001007587-26-000016.md) | [0.8](/filings/0001007587-26-000026.md) |
| Operating income | $m | [(5.2)](/filings/0001007587-24-000013.md) | [(12.2) d](/filings/0001007587-25-000003.md) | [(3.8)](/filings/0001007587-25-000008.md) | [(2.9)](/filings/0001007587-25-000012.md) | [(2.0)](/filings/0001007587-25-000022.md) | [(3.2) d](/filings/0001007587-26-000004.md) | [(2.2)](/filings/0001007587-26-000016.md) | [(0.4)](/filings/0001007587-26-000026.md) | [(7.6)](/filings/0001007587-25-000022.md) | [(0.9) d](/filings/0001007587-26-000004.md) | [(0.1)](/filings/0001007587-26-000016.md) | [(0.1)](/filings/0001007587-26-000026.md) |
| Interest expense | $m | [0.0](/filings/0001007587-23-000011.md) | [0.0 d](/filings/0001007587-24-000003.md) | not reported | not reported | [0.0](/filings/0001007587-25-000022.md) | [0.0 d](/filings/0001007587-26-000004.md) | [0.0](/filings/0001007587-26-000016.md) | [0.0](/filings/0001007587-26-000026.md) | [0.0](/filings/0001007587-25-000022.md) | [0.0 d](/filings/0001007587-26-000004.md) | [(0.0)](/filings/0001007587-26-000016.md) | [0.0](/filings/0001007587-26-000026.md) |
| Income tax | $m | [0.1](/filings/0001007587-24-000013.md) | [0.2 d](/filings/0001007587-25-000003.md) | [0.1](/filings/0001007587-25-000008.md) | [(0.0)](/filings/0001007587-25-000012.md) | [0.1](/filings/0001007587-25-000022.md) | [0.3 d](/filings/0001007587-26-000004.md) | [0.0](/filings/0001007587-26-000016.md) | [0.1](/filings/0001007587-26-000026.md) | [0.0](/filings/0001007587-25-000022.md) | [(0.3) d](/filings/0001007587-26-000004.md) | [0.1](/filings/0001007587-26-000016.md) | [0.2](/filings/0001007587-26-000026.md) |
| Net income | $m | [(4.4)](/filings/0001007587-24-000013.md) | [(12.2) d](/filings/0001007587-25-000003.md) | [(3.2)](/filings/0001007587-25-000008.md) | [(2.4)](/filings/0001007587-25-000012.md) | [(1.2)](/filings/0001007587-25-000022.md) | [(4.3) d](/filings/0001007587-26-000004.md) | [(1.7)](/filings/0001007587-26-000016.md) | [0.9](/filings/0001007587-26-000026.md) | [(6.9)](/filings/0001007587-25-000022.md) | [0.3 d](/filings/0001007587-26-000004.md) | [0.6](/filings/0001007587-26-000016.md) | [0.2](/filings/0001007587-26-000026.md) |
| Diluted EPS | $ per share | [(0.23)](/filings/0001007587-24-000013.md) | not reported | [(0.16)](/filings/0001007587-25-000008.md) | [(0.12)](/filings/0001007587-25-000012.md) | [(0.06)](/filings/0001007587-25-000022.md) | not reported | [(0.09)](/filings/0001007587-26-000016.md) | [0.05](/filings/0001007587-26-000026.md) | [(0.36)](/filings/0001007587-25-000022.md) | not reported | [0.03](/filings/0001007587-26-000016.md) | [0.01](/filings/0001007587-26-000026.md) |
| Basic EPS | $ per share | [(0.23)](/filings/0001007587-24-000013.md) | not reported | [(0.16)](/filings/0001007587-25-000008.md) | [(0.12)](/filings/0001007587-25-000012.md) | [(0.06)](/filings/0001007587-25-000022.md) | not reported | [(0.09)](/filings/0001007587-26-000016.md) | [0.05](/filings/0001007587-26-000026.md) | [(0.36)](/filings/0001007587-25-000022.md) | not reported | [0.03](/filings/0001007587-26-000016.md) | [0.01](/filings/0001007587-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.5](/filings/0001007587-23-000011.md) | [11.3](/filings/0001007587-25-000003.md) | [11.4](/filings/0001007587-24-000005.md) | [10.4](/filings/0001007587-24-000008.md) | [14.4](/filings/0001007587-24-000013.md) | [50.6](/filings/0001007587-26-000004.md) | [48.6](/filings/0001007587-25-000008.md) | [55.9](/filings/0001007587-25-000012.md) | [72.8](/filings/0001007587-25-000022.md) | [69.9](/filings/0001007587-26-000026.md) | [59.2](/filings/0001007587-26-000016.md) | [57.7](/filings/0001007587-26-000026.md) |
| Current assets | $m | [130](/filings/0001007587-23-000011.md) | [119](/filings/0001007587-25-000003.md) | [116](/filings/0001007587-24-000005.md) | [118](/filings/0001007587-24-000008.md) | [132](/filings/0001007587-24-000013.md) | [123](/filings/0001007587-26-000004.md) | [122](/filings/0001007587-25-000008.md) | [123](/filings/0001007587-25-000012.md) | [120](/filings/0001007587-25-000022.md) | [118](/filings/0001007587-26-000026.md) | [121](/filings/0001007587-26-000016.md) | [118](/filings/0001007587-26-000026.md) |
| Total assets | $m | [187](/filings/0001007587-23-000011.md) | [173](/filings/0001007587-25-000003.md) | [168](/filings/0001007587-24-000005.md) | [169](/filings/0001007587-24-000008.md) | [167](/filings/0001007587-24-000013.md) | [155](/filings/0001007587-26-000004.md) | [151](/filings/0001007587-25-000008.md) | [152](/filings/0001007587-25-000012.md) | [150](/filings/0001007587-25-000022.md) | [152](/filings/0001007587-26-000026.md) | [155](/filings/0001007587-26-000016.md) | [151](/filings/0001007587-26-000026.md) |
| Current liabilities | $m | [25.7](/filings/0001007587-23-000011.md) | [25.0](/filings/0001007587-25-000003.md) | [22.9](/filings/0001007587-24-000005.md) | [25.1](/filings/0001007587-24-000008.md) | [23.6](/filings/0001007587-24-000013.md) | [15.9](/filings/0001007587-26-000004.md) | [13.1](/filings/0001007587-25-000008.md) | [13.1](/filings/0001007587-25-000012.md) | [15.2](/filings/0001007587-25-000022.md) | [16.7](/filings/0001007587-26-000026.md) | [19.4](/filings/0001007587-26-000016.md) | [16.7](/filings/0001007587-26-000026.md) |
| Total liabilities | $m | [29.9](/filings/0001007587-23-000011.md) | [25.3](/filings/0001007587-25-000003.md) | [23.3](/filings/0001007587-24-000005.md) | [25.5](/filings/0001007587-24-000008.md) | [24.0](/filings/0001007587-24-000013.md) | [16.5](/filings/0001007587-26-000004.md) | [13.6](/filings/0001007587-25-000008.md) | [13.7](/filings/0001007587-25-000012.md) | [19.2](/filings/0001007587-25-000022.md) | [20.5](/filings/0001007587-26-000026.md) | [23.0](/filings/0001007587-26-000016.md) | [20.6](/filings/0001007587-26-000026.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [159](/filings/0001007587-24-000013.md) | [147](/filings/0001007587-26-000004.md) | [145](/filings/0001007587-25-000012.md) | [143](/filings/0001007587-25-000022.md) | [143](/filings/0001007587-25-000022.md) | [139](/filings/0001007587-26-000026.md) | [138](/filings/0001007587-26-000026.md) | [138](/filings/0001007587-26-000026.md) | [131](/filings/0001007587-25-000022.md) | [131](/filings/0001007587-26-000026.md) | [132](/filings/0001007587-26-000026.md) | [130](/filings/0001007587-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.5 d](/filings/0001007587-24-000013.md) | [5.2 d](/filings/0001007587-25-000003.md) | [(0.8)](/filings/0001007587-25-000008.md) | [(14.7) d](/filings/0001007587-25-000012.md) | [1.9 d](/filings/0001007587-25-000022.md) | [0.4 d](/filings/0001007587-26-000004.md) | [(1.3)](/filings/0001007587-26-000016.md) | [5.1 d](/filings/0001007587-26-000026.md) | [9.9 d](/filings/0001007587-25-000022.md) | [3.4 d](/filings/0001007587-26-000004.md) | [(8.3)](/filings/0001007587-26-000016.md) | [1.9 d](/filings/0001007587-26-000026.md) |
| Capital expenditure | $m | [2.4 d](/filings/0001007587-24-000013.md) | [3.5 d](/filings/0001007587-25-000003.md) | [2.4](/filings/0001007587-25-000008.md) | [2.7 d](/filings/0001007587-25-000012.md) | [1.5 d](/filings/0001007587-25-000022.md) | [0.8 d](/filings/0001007587-26-000004.md) | [1.1](/filings/0001007587-26-000016.md) | [2.3 d](/filings/0001007587-26-000026.md) | [1.5 d](/filings/0001007587-25-000022.md) | [5.0](/filings/0001007587-26-000026.md) | [2.6](/filings/0001007587-26-000016.md) | [1.2 d](/filings/0001007587-26-000026.md) |
| Share repurchases | $m | [0.0 d](/filings/0001007587-24-000013.md) | [0.0 d](/filings/0001007587-25-000003.md) | [0.0](/filings/0001007587-25-000008.md) | [0.0 d](/filings/0001007587-25-000012.md) | [0.0 d](/filings/0001007587-25-000022.md) | [0.0 d](/filings/0001007587-26-000004.md) | [0.2](/filings/0001007587-26-000016.md) | [1.1 d](/filings/0001007587-26-000026.md) | [0.1 d](/filings/0001007587-25-000022.md) | [0.4 d](/filings/0001007587-26-000004.md) | [0.2](/filings/0001007587-26-000016.md) | [2.3 d](/filings/0001007587-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.7](/filings/0001007587-23-000011.md) | [19.0](/filings/0001007587-24-000005.md) | [19.3](/filings/0001007587-24-000008.md) | [19.2](/filings/0001007587-24-000013.md) | [19.3](/filings/0001007587-25-000008.md) | [19.4](/filings/0001007587-25-000012.md) | [19.4](/filings/0001007587-25-000022.md) | [19.5](/filings/0001007587-26-000016.md) | [19.4](/filings/0001007587-26-000026.md) | [19.4](/filings/0001007587-25-000022.md) | [19.4](/filings/0001007587-26-000016.md) | [19.7](/filings/0001007587-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,140,962 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001007587-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.